Company profile
Mologic LTD.
AgriAlert | Global Leader In Animal Health Diagnostics | GADx
At GADx we have a strong history of developing personalized lateral flow rapid diagnostic tests for livestock, aquaculture, crops...
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts With Accounts Type Small
Accounts AnalysedAA | Transaction MzUxMzExMzI1MGFkaXF6a2N4
Published 28 Mar 2026 09:37
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
HERALD: Revolutionizing Livestock Disease Detection Through Advanced Diagnostics
1 Apr 2026 to 31 Mar 2027
**HERALD (Health Enhancement through Rapid Assessment of Livestock Diseases)** is a collaborative project delivering fast, practical diagnostics for Johne's disease (JD) in cattle, with limited feasibility work preparing the platform for future bovine tuberculosis applications. JD is widespread and costly for dairy and beef producers, undermining animal w...
Diagnostic and Antibiotic Stewardship for Urinary Tract Infections Using Fit-for-Purpose Diagnostic Tools
1 Mar 2025 to 31 Aug 2028
Urinary Tract Infections (UTIs) and antimicrobial resistance (AMR) pose significant global health threats, characterised by high incidence and mortality. However, in Sub-Saharan Africa (SSA), there is often a lack of accessible diagnostics to guide proper treatment and therapy monitoring. Our objectives are as follows: (1) Develop and validate a two-tier ...
Digital Innovations and for Infectious Diseases in Africa
1 Oct 2022 to 30 Sep 2027
no public description
A holistic approach in patient management and epidemic surveillance through convergence of diagnostic technologies, capacity building and stakeholder engagement
1 Sep 2022 to 31 Aug 2025
no public description
Establishment of mammalian cell expression systems for the production of essential low cost protein reagents for development of rapid diagnostics
1 Jan 2021 to 31 Dec 2023
The current SARS-CoV-2 pandemic has highlighted the need for access to rapidly produced, reliable diagnostics with the required sensitivity and specificity at a cost that makes these widely accessible to lower and middle income (LMICs) as well as higher income countries. Protein based diagnostic development and manufacture is reliant upon the availability...
IMPROVED Q FEVER VACCINE (DSTL, PHE, ICENI DX & MOLOGIC)
1 Feb 2018 to 31 Mar 2022
This project addresses the need for new vaccines for global epidemics by the development of a virus-like particle (VLP) based platform technology to deliver a vaccine against Q Fever. The causal agent of Q fever, Coxiella burnetii has been identified as an agent of concern due to its low infectious dose, the ability of the organism to survive for long per...
COPD Exacerbation Alert for patient stratification
1 Jul 2017 to 31 Mar 2021
COPD is the second most common cause of emergency admissions in the UK, responsible for one in eight (130,000) acute adult medical admissions. It is a global problem, with 210 million sufferers and 3 million deaths annually (WHO, 2009). There are 1.2M COPD patients in the UK. Patients with COPD have daily symptoms, a poorer health status, reduced exercise...
Semi-automated on-site quantification of airborne pathogen inoculum to predict the strawberry fruit rot risks
1 Apr 2017 to 30 Jun 2020
Reducing fungal fruit rot is a priority in strawberry production in the UK; annual economic losses due to fungal rotting are usually between £30 to £60M. Rot is mainly caused by Botrytis cinerea, Mucor spp. and Rhizopus spp., with their relative prevalence varying over time and growing site. Most strawberry production in the UK is under protection where t...
SEPSIS Alert Test
1 Jan 2017 to 30 Jun 2019
Sepsis is one of the most common deadly diseases and one of the leading causes of death in the developed world exerting a huge human and economic toll. In the UK there are over 100,000 cases and 37,000 deaths annually. Rapid diagnosis is critical to the effective treatment of the patient and offers the prospect of reduced mortality but existing diagnostic...
Improved Q Fever Vaccine (DSTL, PHE, ICENI DX & Mologic)
1 Sep 2016 to 31 Aug 2017
Virus-like particles (VLPs) are a flexible delivery platform that provides potential for presenting multiple antigens to the immune system concurrently. Hepatitis B core antigen self assembles to form highly stable, immunogenic VLPs in a relatively low cost yeast expression system. The viral protein can be adapted to display foreign antigens on spikes tha...
COPD Exacerbation Alert for patient stratification
1 Mar 2016 to 30 Nov 2016
Our target is to develop a simple, easy to use, diagnostic system for use in the home by COPD patients to gain early warning of acute exacerbation (AECOPD) and stratify them to the most suitable and effective therapy. This will determine the use of antibiotic, anti-inflammatory or bronchodilator medication (combinations of some of these might be required)...
Project SABRINA (Sepsis Alert Biomarkers Resolved In a Novel Assay)
1 Jul 2012 to 30 Jun 2015
A simple, easy to use, rapid, inexpensive, effective, point of care (POC) immunodiagnostic system for early confirmation of sepsis in at-risk patients is to be developed and validated. The biomarkers will include IL-6, C-reactive protein and soluble ICAM-1. These known biomarkers will be integrated via a new algorithm with other physical/clinical indicato...